Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neotropix, Inc.

Latest From Neotropix, Inc.

Novartis's dispersible ACT treatment set to improve malaria treatment in children

A new formulation of the malaria treatment Coartem designed specifically for children has been developed and launched by Novartisand the Medicines for Malaria Venture(MMV).

Start-Up Previews (5/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Heart Valve Repair and Replacement, features profiles of 3F Therapeutics, Arbor Surgical Technologies and Heart Leaflet Technologies. Plus these Start-Ups Across Health Care: Neotropix, NeuroHealing Pharmaceuticals, Othera Pharmaceuticals and Vitra Bioscience.

Neotropix Inc.

Neotropix Inc. believes it is on the right track to develop a virus that just infects cancer cells, at least for cancers with specific neuroendocrine properties -- a feat that would amount to the mythic "silver bullet" cancer cure.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register